{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:13:51Z","timestamp":1794557631620,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institute of Health","award":["R01HL159973"],"award-info":[{"award-number":["R01HL159973"]}]},{"name":"National Cancer Institute","award":["P30CA134274"],"award-info":[{"award-number":["P30CA134274"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00262-023-03445-z","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T11:02:11Z","timestamp":1681556531000},"page":"2549-2556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases"],"prefix":"10.1007","volume":"72","author":[{"given":"Sagarina","family":"Thapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,15]]},"reference":[{"issue":"5","key":"3445_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.smim.2014.01.003","volume":"26","author":"CJ Padro","year":"2014","unstructured":"Padro CJ, Sanders VM (2014) Neuroendocrine regulation of inflammation. Semin Immunol 26(5):357\u2013368","journal-title":"Semin Immunol"},{"issue":"2","key":"3445_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbi.2011.08.001","volume":"26","author":"VM Sanders","year":"2012","unstructured":"Sanders VM (2012) The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet? Brain Behav Immun 26(2):195\u2013200","journal-title":"Brain Behav Immun"},{"issue":"4","key":"3445_CR3","first-page":"595","volume":"52","author":"IJ Elenkov","year":"2000","unstructured":"Elenkov IJ et al (2000) The sympathetic nerve\u2013an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52(4):595\u2013638","journal-title":"Pharmacol Rev"},{"issue":"6","key":"3445_CR4","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s12026-017-8966-3","volume":"65","author":"J Herve","year":"2017","unstructured":"Herve J et al (2017) beta2-adrenergic stimulation of dendritic cells favors IL-10 secretion by CD4(+) T cells. Immunol Res 65(6):1156\u20131163","journal-title":"Immunol Res"},{"issue":"7","key":"3445_CR5","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.4049\/jimmunol.1201391","volume":"190","author":"J Herve","year":"2013","unstructured":"Herve J et al (2013) beta2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells. J Immunol 190(7):3163\u20133171","journal-title":"J Immunol"},{"issue":"2","key":"3445_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4049\/jimmunol.1501206","volume":"196","author":"MC Takenaka","year":"2016","unstructured":"Takenaka MC et al (2016) Norepinephrine Controls Effector T Cell Differentiation through beta2-Adrenergic Receptor-Mediated Inhibition of NF-kappaB and AP-1 in Dendritic Cells. J Immunol 196(2):637\u2013644","journal-title":"J Immunol"},{"key":"3445_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbi.2018.09.004","volume":"74","author":"D Agac","year":"2018","unstructured":"Agac D et al (2018) The beta2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion. Brain Behav Immun 74:176\u2013185","journal-title":"Brain Behav Immun"},{"issue":"7","key":"3445_CR8","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.4049\/jimmunol.1701752","volume":"200","author":"H Mohammadpour","year":"2018","unstructured":"Mohammadpour H et al (2018) Blockade of Host beta2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs. J Immunol 200(7):2479\u20132488","journal-title":"J Immunol"},{"issue":"9","key":"3445_CR9","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.4049\/jimmunol.158.9.4200","volume":"158","author":"VM Sanders","year":"1997","unstructured":"Sanders VM et al (1997) Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 158(9):4200\u20134210","journal-title":"J Immunol"},{"issue":"4","key":"3445_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/brbi.2000.0603","volume":"14","author":"DS Ramer-Quinn","year":"2000","unstructured":"Ramer-Quinn DS et al (2000) Cytokine production by naive and primary effector CD4+ T cells exposed to norepinephrine. Brain Behav Immun 14(4):239\u2013255","journal-title":"Brain Behav Immun"},{"issue":"4","key":"3445_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/eji.201243005","volume":"43","author":"MG Guereschi","year":"2013","unstructured":"Guereschi MG et al (2013) Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner. Eur J Immunol 43(4):1001\u20131012","journal-title":"Eur J Immunol"},{"issue":"8","key":"3445_CR12","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/eji.201646395","volume":"46","author":"LD Estrada","year":"2016","unstructured":"Estrada LD, Agac D, Farrar JD (2016) Sympathetic neural signaling via the beta2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8(+) T-cell effector function. Eur J Immunol 46(8):1948\u20131958","journal-title":"Eur J Immunol"},{"issue":"1","key":"3445_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00262-018-2243-8","volume":"68","author":"G Qiao","year":"2019","unstructured":"Qiao G et al (2019) beta-Adrenergic signaling blocks murine CD8(+) T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol Immunother 68(1):11\u201322","journal-title":"Cancer Immunol Immunother"},{"issue":"6379","key":"3445_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.aan4829","volume":"359","author":"S Moriyama","year":"2018","unstructured":"Moriyama S et al (2018) beta(2)-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses. Science 359(6379):1056\u20131061","journal-title":"Science"},{"issue":"20","key":"3445_CR15","doi-asserted-by":"publisher","first-page":"eaay1497","DOI":"10.1126\/sciadv.aay1497","volume":"6","author":"T Liu","year":"2020","unstructured":"Liu T et al (2020) Local sympathetic innervations modulate the lung innate immune responses. Sci Adv 6(20):eaay1497","journal-title":"Sci Adv"},{"issue":"13","key":"3445_CR16","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1084\/jem.20141132","volume":"211","author":"A Nakai","year":"2014","unstructured":"Nakai A et al (2014) Control of lymphocyte egress from lymph nodes through beta2-adrenergic receptors. J Exp Med 211(13):2583\u20132598","journal-title":"J Exp Med"},{"issue":"12","key":"3445_CR17","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1084\/jem.20160723","volume":"213","author":"K Suzuki","year":"2016","unstructured":"Suzuki K et al (2016) Adrenergic control of the adaptive immune response by diurnal lymphocyte recirculation through lymph nodes. J Exp Med 213(12):2567\u20132574","journal-title":"J Exp Med"},{"key":"3445_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbi.2018.08.017","volume":"74","author":"RM Graff","year":"2018","unstructured":"Graff RM et al (2018) beta(2)-Adrenergic receptor signaling mediates the preferential mobilization of differentiated subsets of CD8+ T-cells, NK-cells and non-classical monocytes in response to acute exercise in humans. Brain Behav Immun 74:143\u2013153","journal-title":"Brain Behav Immun"},{"issue":"6","key":"3445_CR19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s12192-020-01136-7","volume":"25","author":"HE Kunz","year":"2020","unstructured":"Kunz HE et al (2020) The effects of beta1 and beta1+2 adrenergic receptor blockade on the exercise-induced mobilization and ex vivo expansion of virus-specific T cells: implications for cellular therapy and the anti-viral immune effects of exercise. Cell Stress Chaperones 25(6):993\u20131012","journal-title":"Cell Stress Chaperones"},{"issue":"2","key":"3445_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1615\/CritRevImmunol.2019031188","volume":"39","author":"W Wang","year":"2019","unstructured":"Wang W, Cao X (2019) Beta-Adrenergic Signaling in Tumor Immunology and Immunotherapy. Crit Rev Immunol 39(2):93\u2013103","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"3445_CR21","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41467-020-15676-0","volume":"11","author":"M Chen","year":"2020","unstructured":"Chen M et al (2020) Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation. Nat Commun 11(1):1821","journal-title":"Nat Commun"},{"key":"3445_CR22","doi-asserted-by":"publisher","first-page":"6426","DOI":"10.1038\/ncomms7426","volume":"6","author":"JW Eng","year":"2015","unstructured":"Eng JW et al (2015) Housing temperature-induced stress drives therapeutic resistance in murine tumour models through beta2-adrenergic receptor activation. Nat Commun 6:6426","journal-title":"Nat Commun"},{"issue":"20","key":"3445_CR23","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","volume":"77","author":"MJ Bucsek","year":"2017","unstructured":"Bucsek MJ et al (2017) beta-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8(+) T Cells and Undermines Checkpoint Inhibitor Therapy. Cancer Res 77(20):5639\u20135651","journal-title":"Cancer Res"},{"issue":"50","key":"3445_CR24","doi-asserted-by":"publisher","first-page":"20176","DOI":"10.1073\/pnas.1304291110","volume":"110","author":"KM Kokolus","year":"2013","unstructured":"Kokolus KM et al (2013) Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proc Natl Acad Sci U S A 110(50):20176\u201320181","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3445_CR25","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.3389\/fimmu.2019.03082","volume":"10","author":"FL Baker","year":"2019","unstructured":"Baker FL et al (2019) Systemic beta-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vgamma9Vdelta2 T-Cells. Front Immunol 10:3082","journal-title":"Front Immunol"},{"issue":"7","key":"3445_CR26","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1185\/03007995.2014.890928","volume":"30","author":"Y Du","year":"2014","unstructured":"Du Y et al (2014) Association of alpha2a and beta2 adrenoceptor expression with clinical outcome in breast cancer. Curr Med Res Opin 30(7):1337\u20131344","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"3445_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10549-019-05341-6","volume":"177","author":"S Kurozumi","year":"2019","unstructured":"Kurozumi S et al (2019) beta2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer. Breast Cancer Res Treat 177(3):603\u2013610","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3445_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10549-010-0822-2","volume":"125","author":"M Shi","year":"2011","unstructured":"Shi M et al (2011) The beta2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Breast Cancer Res Treat 125(2):351\u2013362","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3445_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/onc.2015.58","volume":"35","author":"D Liu","year":"2016","unstructured":"Liu D et al (2016) beta2-AR signaling controls trastuzumab resistance-dependent pathway. Oncogene 35(1):47\u201358","journal-title":"Oncogene"},{"issue":"1","key":"3445_CR30","first-page":"341","volume":"41","author":"WY Xie","year":"2019","unstructured":"Xie WY et al (2019) betablockers inhibit the viability of breast cancer cells by regulating the ERK\/COX2 signaling pathway and the drug response is affected by ADRB2 singlenucleotide polymorphisms. Oncol Rep 41(1):341\u2013350","journal-title":"Oncol Rep"},{"issue":"3","key":"3445_CR31","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4143\/crt.2019.510","volume":"52","author":"J Zhou","year":"2020","unstructured":"Zhou J et al (2020) Activation of beta2-Adrenergic Receptor Promotes Growth and Angiogenesis in Breast Cancer by Down-regulating PPARgamma. Cancer Res Treat 52(3):830\u2013847","journal-title":"Cancer Res Treat"},{"issue":"5","key":"3445_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5483\/BMBRep.2015.48.5.008","volume":"48","author":"JF Qin","year":"2015","unstructured":"Qin JF et al (2015) Adrenergic receptor beta2 activation by stress promotes breast cancer progression through macrophages M2 polarization in tumor microenvironment. BMB Rep 48(5):295\u2013300","journal-title":"BMB Rep"},{"issue":"12","key":"3445_CR33","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour H et al (2019) beta2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest 129(12):5537\u20135552","journal-title":"J Clin Invest"},{"issue":"10","key":"3445_CR34","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.4049\/jimmunol.1500700","volume":"195","author":"ND Leigh","year":"2015","unstructured":"Leigh ND et al (2015) Housing Temperature-Induced Stress Is Suppressing Murine Graft-versus-Host Disease through beta2-Adrenergic Receptor Signaling. J Immunol 195(10):5045\u20135054","journal-title":"J Immunol"},{"key":"3445_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137788","author":"H Mohammadpour","year":"2020","unstructured":"Mohammadpour H et al (2020) \u03b22-Adrenergic receptor activation on donor cells ameliorates acute GvHD. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.137788","journal-title":"JCI Insight"},{"issue":"12","key":"3445_CR36","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1136\/ard.2007.083782","volume":"67","author":"O Malysheva","year":"2008","unstructured":"Malysheva O et al (2008) Association between beta2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope. Ann Rheum Dis 67(12):1759\u20131764","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3445_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/03009740410010326","volume":"33","author":"B Xu","year":"2004","unstructured":"Xu B et al (2004) beta2-adrenergic receptor gene single-nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden. Scand J Rheumatol 33(6):395\u2013398","journal-title":"Scand J Rheumatol"},{"key":"3445_CR38","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3389\/fphar.2018.01313","volume":"9","author":"L Wu","year":"2018","unstructured":"Wu L et al (2018) Bidirectional Role of beta2-Adrenergic Receptor in Autoimmune Diseases. Front Pharmacol 9:1313","journal-title":"Front Pharmacol"},{"issue":"4","key":"3445_CR39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.neuint.2010.02.012","volume":"57","author":"J De Keyser","year":"2010","unstructured":"De Keyser J et al (2010) Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis. Neurochem Int 57(4):446\u2013450","journal-title":"Neurochem Int"},{"issue":"8","key":"3445_CR40","first-page":"666","volume":"35","author":"M Durfinova","year":"2014","unstructured":"Durfinova M et al (2014) Role of astrocytes in pathogenesis of multiple sclerosis and their participation in regulation of cerebral circulation. Neuro Endocrinol Lett 35(8):666\u2013672","journal-title":"Neuro Endocrinol Lett"},{"issue":"12","key":"3445_CR41","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.celrep.2019.08.042","volume":"28","author":"LP Araujo","year":"2019","unstructured":"Araujo LP et al (2019) The sympathetic nervous system mitigates CNS autoimmunity via \u03b22-adrenergic receptor signaling in immune cells. Cell Rep 28(12):3120-3130.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.08.042","journal-title":"Cell Rep"},{"issue":"4","key":"3445_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/00207454.2016.1202952","volume":"127","author":"L Wang","year":"2017","unstructured":"Wang L, Zhang Y, He M (2017) beta2-Adrenergic receptor gene polymorphisms in the relapse of myasthenia gravis with thymus abnormality. Int J Neurosci 127(4):291\u2013298","journal-title":"Int J Neurosci"},{"issue":"2","key":"3445_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087840","volume":"9","author":"N Ghazanfari","year":"2014","unstructured":"Ghazanfari N et al (2014) Effects of the ss2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis. PLoS ONE 9(2):e87840","journal-title":"PLoS ONE"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03445-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-023-03445-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03445-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:02:20Z","timestamp":1689984140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-023-03445-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3445"],"URL":"https:\/\/doi.org\/10.1007\/s00262-023-03445-z","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,15]]},"assertion":[{"value":"12 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}